Pharmaceutical Technology - April 2024

Pharmaceutical Technology - April 2024

Issue link: https://www.e-digitaleditions.com/i/1519174

Contents of this Issue

Navigation

Page 6 of 18

As mRNA technologies and industry regulations evolve, the development process often requires navigating through unknown circumstances. But this isn't a journey you have to go on alone. At Thermo Fisher Scientific, we focus on understanding the unique needs of your mRNA-based vaccine or therapeutic so we can innovate tailored solutions to address them. Leveraging our extensive experience as a pharma services provider, combined with access to technical expertise and resources across our global network, we provide personalized support and adaptability to chart your own path with confidence. mRNA product development demands adaptability Find your missing element with Thermo Fisher Scientific. © 2024 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified. ili A Adaptab ty 10 Learn how we can support your unique mRNA product journey from development to delivery. Our flexible, end-to-end mRNA CDMO solutions include: • Translational services • mRNA synthesis • Encapsulation • Sterile fill-finish • Cold chain logistics

Articles in this issue

Links on this page

Archives of this issue

view archives of Pharmaceutical Technology - April 2024 - Pharmaceutical Technology - April 2024